About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Study Reveals New Method to Delay Evolution of Drug Resistance in Malaria Parasite

by Rajashri on September 6, 2008 at 3:12 PM
Font : A-A+

 Study Reveals New Method to Delay Evolution of Drug Resistance in Malaria Parasite

A new method that effectively delays the evolution of drug resistance in malaria parasites has been devised by researchers at the University of Florida.

David Smith, associate director of disease ecology at UF's Emerging Pathogens Institute and study's co-author, said that the new research would help scientists and policy makers in extending the longevity of current artemisinin-based malaria drugs combined with partner drugs.

Advertisement

Smith and colleagues created mathematical models assessing the strategic effectiveness and clinical outcomes of using one, two and three first-line drug therapies to treat malaria within a population over a 20-year period.

They found that using two or three drugs simultaneously reduced the total clinical cases and number of failed treatments, and slowed the rate at which drug-resistant genes spread within the parasites that cause malaria: Plasmodium falciparum, P. vivax, P. malariae and P. ovale.
Advertisement

"The models indicate that we can slow the evolution of resistance to current artemisinin-based therapies if nations use them in combination with two or more partner drugs," Smith said.

Smith said that artemisinin-combined therapies, or ACTs, are currently not widely implemented due to operational challenges and expense. However, he said that the study offers compelling evidence for global leaders to collaborate and overcome these issues.

"This is not to say that implementing multiple first-line therapies solves all of our malaria problems. Anti-malarial drug development needs to continue so that we have novel and highly effective anti-malarials that can be plugged into the recommended strategy of deploying multiple therapies," Boni said.

Artemesinin drugs, derived from the herb Artemisia annua, are relatively new and the malaria parasite does not yet appear to have a resistance to it. They work by triggering chemical reactions, which damage the Plasmodium parasite.

"We don't have anything in the pipeline after ACTs, and it's basically just a matter of time until drug resistance evolves and artemisinin also fails. So the question becomes how do we keep ACTs in our arsenal for as long as effectively possible?" Smith said.

The researchers' models also show that cycling through single drugs accelerated the rate at which malaria parasites evolved drug resistance.

Smith said this occurred because cycling a single drug degraded the parasite's average fitness, which made it easier for drug-resistant genes to spread throughout the parasite population.

The cycling models predicted a declining therapeutic value of a single drug within 3.54 years, versus a longer effective therapeutic value of 9.95 years when three drugs were used in equal proportions within a population.

"Using multiple first-line drugs reduces the selection pressure for resistance to a single drug. This is one way to make the ACTs last longer and benefit more people," Smith said.

The study is scheduled to publish online this week in the Proceedings of the National Academy of Sciences and in print on Sept. 16.

Source: ANI
RAS/L
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Sensory Processing Disorder (SPD)
First Dose of COVID-19 Vaccines May Improve Mental Health
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Malaria-water Malaria Mosquito Diseases Trypanosomiasis Signature Drug Toxicity Drug Resistance - Antibiotic Resistance Fever Malaria - Protection Strategies Antibiotic Resistance - An Emerging Global Crisis 

Recommended Reading
Malaria
Malaria is caused by a parasite that enters blood through the bite of an infected mosquito. It is .....
Mosquito Diseases
Mosquito-borne diseases, like malaria, filaria, dengue, etc are common in places conducive of ......
Waterborne Disease - Animation
Interactive section of Medindia gives details regarding waterborne disease...
Study Finds Malaria Spurt Sparked After the Parasite Learnt to Switch Hosts
In a breakthrough study, researchers at Osaka University in Japan have found that the spurt of ......
Antibiotic Resistance - An Emerging Global Crisis
Antibiotic resistance refers to the adaption of bacteria that allows them to grow even in the presen...
Drug Resistance - Antibiotic Resistance
Drug resistance is often a problem in malaria, tuberculosis, HIV, sexually transmitted diseases and ...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Fever
Fever or Pyrexia is an elevation in normal body temperature. Causes of fever include infections, inj...
Malaria - Protection Strategies
Malaria is a dangerous disease with lethal consequences that requires protective measures for preven...
Trypanosomiasis
Sleeping sickness or Trypanosomiasis is a vector-borne parasitic disease which can trigger life-thre...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use